State Street Corp Bristol Myers Squibb CO Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Street Corp holds 91,445,366 shares of BMY stock, worth $4.58 Billion. This represents 0.17% of its overall portfolio holdings.

Number of Shares

91,445,366

Previous 91,571,110 0.14%

Holding current value

$4.58 Billion

Previous $4.97 Billion 23.52%

% of portfolio

0.17%

Previous 0.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $5.06 Million - $6.66 Million	-125,744 Reduced 0.14%	91,445,366 $3.8 Billion
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $102 Million - $116 Million	2,124,904 Added 2.38%	91,571,110 $4.97 Billion
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $1.36 Million - $1.62 Million	-28,038 Reduced 0.03%	89,446,206 $4.59 Billion
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $179 Million - $200 Million	-3,096,044 Reduced 3.34%	89,474,244 $5.19 Billion
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $54.7 Million - $60.8 Million	858,922 Added 0.94%	92,570,288 $5.92 Billion
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $68.2 Million - $77.4 Million	-1,038,635 Reduced 1.12%	91,711,366 $6.36 Billion
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $29 Million - $34.4 Million	424,103 Added 0.46%	92,750,001 $6.67 Billion
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $78,321 - $46.3 Million	-602,471 Reduced 0.65%	92,325,898 $6.56 Billion
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $109 Million - $120 Million	-1,502,652 Reduced 1.59%	92,928,369 $7.2 Billion
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $13.2 Million - $15.8 Million	-214,951 Reduced 0.23%	94,431,021 $6.95 Billion
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $108 Million - $126 Million	2,020,678 Added 2.18%	94,645,972 $5.9 Billion
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $28.4 Million - $33.3 Million	479,946 Added 0.52%	92,625,294 $5.53 Billion
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $74.1 Million - $80.7 Million	1,196,435 Added 1.32%	92,145,348 $6.16 Billion
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $191 Million - $215 Million	-3,214,972 Reduced 3.41%	90,948,913 $5.79 Billion
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $192 Million - $218 Million	-3,327,247 Reduced 3.41%	94,163,885 $5.89 Billion
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $91.2 Million - $101 Million	-1,587,880 Reduced 1.6%	97,491,132 $5.88 Billion
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $97.2 Million - $114 Million	-1,773,560 Reduced 1.76%	99,079,012 $5.83 Billion
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $4.68 Billion - $6.8 Billion	100,852,572 New	100,852,572 $5.62 Billion

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $107B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Bristol Myers Squibb CO Transaction History